Extracorporeal high-intensity focused ultrasound for VX2 liver tumors in the rabbit.
High-Intensity Focused Ultrasound (HIFU) can produce radical tissue necrosis. We wanted to assess tumor destruction, proliferation, and tumorigenesis after HIFU, in an animal model of hepatic tumor. New Zealand rabbits bearing VX-2 solitary liver tumors were treated with extracorporeal HIFU under ultrasound (US) guidance and standardized conditions. Groups differed only for the administration of either one or two consecutive HIFU procedures. Tissue destruction was assessed by stereomicroscopy and planimetry, cell proliferation was estimated by in vivo intra-arterial injection of 1200 muCi [3H]thymidine, and tumorigenesis was tested by reimplantation of treated or untreated pieces of liver tumors into the thighs of nontumor-bearing animals. Mortality was 0. Tumor destruction rates were 76.3% +/- 16% after one procedure and 94.2% +/- 7.3% after two procedures. Nuclear staining was heavy in control tumors and was absent in treated tumors. Untreated hepatic tumors induced measurable tumors at 3 weeks in thighs of all recipients, 7.8 +/- 2.4 cm3 in volume. Hepatic tumors treated with one HIFU procedure induced tumors in the thigh of recipients in 31.3% of cases (0.47 +/- 0.06 cm3), and those treated with two HIFU procedures induced tumors in 0% even after 8 weeks of follow-up. In conclusion, HIFU allows a noninvasive approach to the destruction of liver tumors in this model, with little toxicity but significant effects on proliferation and tumorigenesis. The repetition of HIFU procedures may improve results.
Prat
F
F
INSERM U281, Lyon, France.
Centarti
M
M
Sibille
A
A
Abou el Fadil
F A
FA
Henry
L
L
Chapelon
J Y
JY
Cathignol
D
D
D000818:Animals; D001345:Autoradiography; D002277:Carcinoma / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D005260:Female; D007269:Injections, Intra-Arterial; D008113:Liver Neoplasms / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D008297:Male; D009368:Neoplasm Transplantation; D011817:Rabbits; D013936:Thymidine / Q000493:pharmacokinetics; D014464:Ultrasonic Therapy / Q000295:instrumentation
D013936:Thymidine